CHKA and neoplasm: In the past, the RAS signaling pathway was found to regulate CHKα expression during tumor progression via phosphoinositide 3-kinase (PI3K) [55, 57, 58], thus directly linking CHKα activity to known oncogenes and signaling pathways driving tumor progression.